Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDirecta Plus Regulatory News (DCTA)

  • This share is currently suspended. It was suspended at a price of 6.75
  • There is currently no data for DCTA

Significant Tender Win

28 Jul 2021 09:12

RNS Number : 7493G
Directa Plus PLC
28 July 2021
 

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION (596/2014) WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. UPON THE PUBLICATION OF THE ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN

 

28 July 2021

 

Directa Plus plc

("Directa Plus" or the "Company")

 

Significant Further Tender Win from OMV Petrom

 

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, announces that it has won an additional tender from OMV Petrom, the largest oil and gas group in south-eastern Europe, for the provision of waste treatment services utilising the Company's Grafysorber® and the supply of related products. The four-year contract has a total value of €3,200,000, with an invoice value of approximately €800,000 per annum, and is expected to commence in August 2021.

 

OMV's objectives are to improve the oil production process in one of the company's upstream production assets in Romania and to contain production costs by applying the most effective technology solution to the treatment of produced water and sludges while preventing oil spills and providing remediation services. It is expected that approximately 80,000 cubic meters of sludge and waste produced during the first upstream separation process will be treated over the four year contract period and that up to 20,000 tons of crude oil with impurities below 1% will be recovered and sent to the refinery.

 

In addition, it is expected that some 50,000 cubic meters of produced water will be treated over the same period using dedicated engineering equipment, increasing water injection quality while meeting national regulations to minimise the use of water resources. Directa Plus will supply a total of 700 highly-performant adsorbent devices containing Grafysorber® to OMV Petrom to insulate, clean and eliminate any accidental oil spills during the workover and intervention operations, mitigating any environmental impact.

 

Directa Plus's patented Grafysorber® technology is a graphene-based solution for treating water sludges and emulsions containing hydrocarbons and is at least five times more effective than current technologies - adsorbing more than 100 times its own weight of oil-based pollutants. In addition, Grafysorber® is sustainably produced, non-flammable and reusable, with the adsorbed hydrocarbons recoverable.

 

Commenting, Giulio Cesareo, Founder and CEO of Directa Plus, said: "This is our second major contract from OMV Petrom. Repeat business demonstrates a satisfied customer which has already seen our technology and services successfully applied to their operations.

 

"With the recent trend of the oil price, we expect more E&P companies will find our oil recovery services attractive. Grafysorber® is continuing to gain traction with and generate interest from the international oil and gas industry that require an environmentally friendly solution to treat produced water and sludges."

 

This announcement has been approved by Giulio Cesareo, Chief Executive, on behalf of the Company.

 

For further information please visit www.directa-plus.com or contact:

 

Directa Plus plc

+39 02 36714458

Giulio Cesareo, CEO

Giorgio Bonfanti, CFO

Cenkos Securities plc (Nominated Adviser and Joint Broker)

+44 131 220 6939

Neil McDonald

Pete Lynch

 

 

 

N+1 Singer (Joint Broker)

+44 20 7496 3069

Rick Thompson

Phil Davies

 

 

 

Tavistock (Financial PR and IR)

+44 20 7920 3150

Simon Hudson

Heather Armstrong

 

 

About Directa Plus

Our focus is principally on the two sectors in which we have strong commercial advantage through developed and launched products and a technological lead: environmental (based on our Grafysorber® product) and textiles (based on our G+® products). In addition, we will continue to pursue opportunities in elastomers and composites (including tyres and asphalt), also using our G+® products. All our products are hypoallergenic, non-toxic and sustainably produced.

 

-ends-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCPPUGGMUPGURR
Date   Source Headline
18th Oct 201911:36 amRNSResult of Open Offer, and GM, Issue of Equity
30th Sep 20192:21 pmRNSAcquisition, Placing and Open Offer
30th Sep 20192:21 pmRNSHalf-year Report
10th Sep 20197:00 amRNSNew Textile Membrane Patent Granted
6th Aug 20198:29 amRNSHolding(s) in Company
29th Jul 20197:00 amRNSAward of Oil Decontamination and Recovery Contract
22nd Jul 20197:00 amRNSHolding(s) in Company
4th Jul 20197:00 amRNSUS Patent Grant for Liquid G+
27th Jun 20197:00 amRNSGrant of US Patent
26th Jun 20199:47 amRNSHolding(s) in Company
18th Jun 20191:36 pmRNSResult of AGM
18th Jun 20197:00 amRNSAGM Statement
17th Jun 20197:00 amRNSHolding(s) in Company
28th May 20197:00 amRNSDirector/PDMR Shareholding
23rd May 20197:00 amRNSNew patent grants
23rd May 20197:00 amRNSPosting of Annual Report and Notice of AGM
7th May 20197:00 amRNSCo-operation agreement with Alfredo Grassi S.p.A.
17th Apr 20197:00 amRNSFinal Results for the Year to 31 December 2018
1st Apr 20197:00 amRNSSuccessful First Road Surface Trial Results
4th Mar 20197:00 amRNS3 Year Exclusive Agreement with Loro Piana
6th Feb 20197:00 amRNSUS National Graphene Association Appointment
31st Jan 20194:41 pmRNSHolding(s) in Company
31st Jan 20199:05 amRNSSecond Price Monitoring Extn
31st Jan 20199:00 amRNSPrice Monitoring Extension
30th Jan 20193:45 pmRNSHolding(s) in Company
30th Jan 201911:00 amRNSHolding(s) in Company
30th Jan 201911:00 amRNSHolding(s) in Company
30th Jan 201911:00 amRNSHolding(s) in Company
8th Jan 201911:58 amRNSResult of General Meeting and Total Voting Rights
7th Jan 20191:00 pmRNSResults of Open Offer
13th Dec 20187:00 amRNSAnnouncement of Open Offer
12th Dec 20183:30 pmRNSResults of Placing
12th Dec 201811:30 amRNSProposed Placing to raise a minimum of £3 million
5th Dec 20187:00 amRNSDirecta Plus to present at Denim Première Vision
29th Nov 20187:00 amRNSCollaboration Agreement with Ambienthesis S.p.A.
23rd Nov 20184:00 pmRNSDirecta Plus to present at Mello London
23rd Nov 20187:00 amRNSEnvironmental Sale and Participation in Trial
22nd Nov 20187:00 amRNSTrading Update
30th Oct 20189:15 amRNSFurther Agreement with Arvind, Launch of G+ Jeans
23rd Oct 20187:00 amRNSSignificant Textiles Order
28th Sep 201812:55 pmRNSDirector/PDMR Shareholding
26th Sep 20182:24 pmRNSReplacement: Director/PDMR Shareholding
26th Sep 201812:52 pmRNSDirector/PDMR Shareholding
26th Sep 20187:00 amRNSWorld's First Road Surface Containing Graphene
25th Sep 20187:00 amRNSHalf-year Report
31st Jul 20187:00 amRNSAppointment of N+1 Singer as Joint Broker
9th Jul 201810:00 amRNSOakley and Bioracer launch Graphene Plus jersey
4th Jul 20187:00 amRNSSecond significant order from Alfredo Grassi
18th Jun 20184:28 pmRNSResult of AGM
18th Jun 20187:00 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.